James L. LaBelle
University of Chicago(US)
Publications by Year
Research Areas
Acute Lymphoblastic Leukemia research, Cancer Immunotherapy and Biomarkers, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → Self-assembling peptide-based building blocks in medical applications(2016)239 cited
- → A stapled BIM peptide overcomes apoptotic resistance in hematologic cancers(2012)173 cited
- → CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease(2023)140 cited
- → Molecular engineering solutions for therapeutic peptide delivery(2017)133 cited
- → Distinct BimBH3 (BimSAHB) Stapled Peptides for Structural and Cellular Studies(2013)95 cited
- → Role of Immunoregulatory Donor T Cells in Suppression of Graft-Versus-Host Disease Following Donor Leukocyte Infusion Therapy(1999)71 cited
- → Multimodal Interaction with BCL-2 Family Proteins Underlies the Proapoptotic Activity of PUMA BH3(2013)68 cited
- → Repression of BIM mediates survival signaling by MYC and AKT in high-risk T-cell acute lymphoblastic leukemia(2014)58 cited
- → Harnessing the Therapeutic Potential of Biomacromolecules through Intracellular Delivery of Nucleic Acids, Peptides, and Proteins(2022)48 cited
- → Negative effect of CTLA-4 on induction of T-cell immunity in vivo to B7-1+, but not B7-2+, murine myelogenous leukemia(2002)47 cited